Xtant Medical Holdings, Inc.

XTNT Healthcare Medical Devices

Xtant Medical Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $133.9 million, up 14.2% from fiscal 2024. In the quarter to June 2026, revenue fell 35.0%, EPS fell 333.3%, free cash flow fell 882.0% and total debt fell 33.0%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

0.28 0.02 −6.67%
Market cap
$42.5M
P/E
0.0×
Fwd P/E
−9.1×
Dividend yield
—
F-score
8/9
Altman Z
0.03
Beneish M
−3.11
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 27.45 19.12 31.86

+8 more quarters

P/S ratio
0.54 0.64 0.81 0.68
P/FCF ratio
0.00 9.81 10.47 16.56
P/Operating CF
(8.06) (37.10) 20.23 19.69
P/B ratio
1.47 1.61 2.14 1.80
EV/Sales
0.65 0.64 0.87 0.82
EV/EBITDA
0.00 9.84 9.35 9.99
EV/FCF
(156.17) 9.82 11.24 19.86
Current Ratio
2.16 3.34 2.65 2.21
Net Debt/EBITDA
(1.47) (0.04) 9.22 4.89
Debt/Equity
0.57 0.25 0.50 0.57
Earnings Yield
(18.95%) 3.64% 5.23% 3.14%
Free Cash Flow Yield
(0.78%) 10.20% 9.55% 6.04%
Free Cash Flow per Share
(0.05) (0.02) 0.04 0.03
Book value per Share
0.29 0.35 0.37 0.36
Free Cash Flow
(7.50) (2.26) 5.01 4.29
EV/EBIT
0.00 23.81 16.05 17.16
Other line items

Show all line items

Columns are period end dates